Product Recalls

MCNEIL CONSUMER HEALTHCARE RECALLS FOUR PRODUCT LOTS OF BENADRYL®
ALLERGY ULTRATAB™ TABLETS, 100 COUNT, AND ONE PRODUCT LOT OF EXTRA
STRENGTH TYLENOL® RAPID RELEASE GELS, 50 COUNT

Fort Washington, PA (June 15, 2010) McNeil Consumer Healthcare, Division of
McNEIL-PPC, Inc., is recalling five product lots as an addition to the list of products
included in the company's January 15th, 2010 product recall. The additional lots
involved are four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100
count, sold in the U.S.; and one product lot of EXTRA STRENGTH TYLENOL® Rapid
Release Gels, 50 count sold in the U.S., Trinidad and Tobago, Bermuda, and Puerto
Rico (FULL RECALLED PRODUCT LIST BELOW). This recall is a follow-up to the
product recall that McNeil Consumer Healthcare announced on January 15th, 2010
and is being taken because the products were inadvertently omitted from the initial
recall action. McNeil Consumer Healthcare identified the omission and informed the
U.S. Food and Drug Administration (FDA) of its decision to add these product lots to
the recall list. All these products were produced before the January 15th, 2010
recall. Since January, McNeil Consumer Healthcare has continued to analyze and
evaluate 2,4,6-tribromoanisole (TBA) and has shared that information with the FDA.
This further analysis confirms that the risk of serious adverse medical events is
remote. This recall is being conducted with the knowledge of the FDA.

BENADRYL® ALLERGY ULTRATAB™ TABLETS is sold over-the-counter and is
indicated for the relief of allergy associated symptoms such as sneezing, runny
nose, itchy throat, and itchy and watery eyes. EXTRA STRENGTH TYLENOL® Rapid
Release Gels is sold over-the-counter and is indicated for the temporary reduction
of fever and for the temporary relief of minor aches and pains due to headache,
muscular aches, backache, minor arthritis pain, the common cold, toothache,
pre-menstrual and menstrual cramps, and flu.

The January 15th, 2010 recall was initiated as a result of consumer complaints of a
musty or moldy odor that has since been linked to the presence of trace amounts of
a chemical called 2,4,6-tribromoanisole (TBA). After a thorough investigation, it was
determined that the source of TBA was the result of a breakdown of a chemical that
is applied to wood used to build wooden pallets that transport and store product
packaging materials.

Consumers who purchased product from the lots included in this recall should stop
using the product and contact McNeil Consumer Healthcare for instructions on a
refund or replacement. For these instructions or information regarding how to
return or dispose of the product, consumers should log on to the internet at
www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 8
p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time).

Requests for reimbursement can be made at www.mcneilproductrecall.com.
Consumers who have medical concerns or questions should contact their
healthcare provider.

Any adverse reactions may also be reported to the FDA's MedWatch Program by fax
at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville,
MD 20852-9787, or on theMedWatch website at
www.fda.gov/safety/medwatch/default.htm.

The product lot numbers for the recalled products can be found on the side of the
bottle label.

FULL RECALLED PRODUCT LIST:
Product Description:
TYLENOL® EXTRA STRENGTH RAPID RELEASE GELCAP 50CT
NDC Code #
50580-488-50
UPC # 300450488503

LOT #s
ASA202

Product Description:
BENADRYL® Allergy ULTRATAB™ 100 COUNT
NDC Code #
50580-226-10
UPC # 312547170338

LOT #s
AJA008 ADA194
ABA022 ABA264